Contract HHSN311201300221P
Applied Stemcell, Inc. · Department Of Health And Human Services · June 18, 2013
Applied Stemcell, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on June 18, 2013 for $9,000 of work in research and development in biotechnology. Performance is in Menlo Park, CA. It was awarded under full and open competition. It uses firm fixed-price contract pricing.
Contract details
- PIID
- HHSN311201300221P
- Award type
- Po
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed Under Sap
- NAICS
- 541711 · Research And Development In Biotechnology
- Product / service
- Drugs And Biologicals
- Place of performance
- Menlo Park, CA
- First action
- June 18, 2013
Description
IGF::OT::IGF GENERATION OF ES CELL TARGETING VECTOR W/MUTATION AT E2385RAPPLIED STEMCELL, INC.:1195286 [13-008746]
Modification timeline
-
June 18, 2013Base award$9.0K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| University Of Illinois | Department Of Health And Human Services | March 26, 2026 | $2.27M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 25, 2026 | $9.65M |
| University Of Texas Medical Branch At Galveston | Department Of Health And Human Services | March 23, 2026 | $1.61M |
| Regeneron Pharmaceuticals Inc | Department Of Health And Human Services | March 19, 2026 | $8.60M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.23M |
| Battelle Memorial Institute | Department Of Health And Human Services | March 17, 2026 | $2.22M |
Top contractors in NAICS 541711
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Alliance For Energy Innovation, Llc | 2 | $10.68B |
| 2 | Emergent Product Development Gaithersburg Inc. | 7 | $1.63B |
| 3 | Janssen Pharmaceuticals, Inc. | 2 | $1.05B |
| 4 | Regeneron Pharmaceuticals Inc | 4 | $1.01B |
| 5 | Siga Technologies, Inc. | 3 | $560.59M |
| 6 | Battelle National Biodefense Institute, Llc | 106 | $469.31M |
| 7 | Glaxosmithkline, Llc | 6 | $321.65M |
| 8 | Merck Sharp & Dohme Llc | 3 | $309.72M |
| 9 | Sri International | 130 | $258.61M |
| 10 | American Type Culture Collection | 7 | $243.18M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract HHSN311201300221P?
Contract HHSN311201300221P is a federal contract awarded to Applied Stemcell, Inc. by Department Of Health And Human Services on June 18, 2013 for $9,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY. It has been modified 0 times since the base award.
Who won contract HHSN311201300221P?
Applied Stemcell, Inc. won contract HHSN311201300221P from Department Of Health And Human Services.
How much is contract HHSN311201300221P worth?
Contract HHSN311201300221P has obligated $9,000 to date.